General testing or proof requirement:
Entrants aged 12 and over must have proof of vaccination, proof of convalescence or a negative COVID-19 test on entry. This applies regardless of the country or means of transport from which the entry is made.
Attention: When entering from a virus variant area, a negative COVID-19 test is always required for entrants aged 12 and over. Proof of vaccination or recovery is not sufficient here. Exceptions to the testing or proof requirement apply to persons in transit without a stopover. In border traffic with a stay of less than 24 hours at a time, the testing or proof requirement only applies to high-risk and virus variant areas or when entering by air. Non-vaccinated or recovered persons in this border traffic only have to show a negative test twice a week. Canada is currently neither classified as a virus variant, nor as a high-risk area.
Quarantine obligation: There is still an obligation to quarantine for persons entering Germany who have stayed in a high-risk area or virus variant area in the last 10 days before entering Germany. For high-risk areas, the previous regulations for high-incidence areas essentially apply. This means that the quarantine does not apply if proof of vaccination or a convalescence certificate is presented. For those who have not been vaccinated or have recovered, the quarantine can be ended at the earliest after 5 days by a negative test. However, with the new regulation, the quarantine obligation for children under twelve years of age ends after 5 days instead of 10 days, even without a test. Canada is currently neither classified as a virus variant, nor as a high-risk area.
Obligation to register:
The existing obligation to register continues to apply to persons entering the country with previous stays in high-risk or virus-variant areas.
As regulations may change upon very short notice, please make sure to stay informed by checking back and reading our latest information here
Further information about vaccination upon entry by the Paul-Ehrlich-Institute: www.pei.de/DE/arzneimittel/impfstoffe/covid-19/covid-19-node.html